Report
FREE
Positive data from Phase IIa of BPX01 for acne announced, Phase IIb initiated. Phase IV of VI2LET initiated, data expected by the end of 2016;
Underlying
BIOPHARMX
Provider
Zacks
Zacks Investment Research is a Chicago based firm with over 30 years of experience in providing institutional and individual investors with the analytical tools and financial information necessary to the success of their investment process.
Other Reports on these Companies
Other Reports from Zacks
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.